Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study

Autor: Ivan Castellví, Diego Castillo, Hèctor Corominas, Anaís Mariscal, Sandra Orozco, Natividad Benito, Virginia Pomar, Andrés Baucells, Isabel Mur, David de la Rosa-Carrillo, David Lobo, Ana Milena Millan, Nerea Hernández de Sosa, David Filella, Laia Matas, Laura Martínez-Martínez, Cándido Juarez, Jordi Casademont, Pere Domingo

Publikováno v: Frontiers in Medicine, Vol 9 (2022)

Coronavirus disease 2019 (COVID-19) has rapidly expanded worldwide. Currently, there are no biomarkers to predict respiratory worsening in patients with mild to moderate COVID-19 pneumonia. Small studies explored the use of Krebs von de Lungen-6 circ

Externí odkaz: https://doaj.org/article/c7d43db410004423b9c0ce430cda69db

Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial

Autor: Jorge M. Núñez-Córdoba, Pilar Llamas, Jose Yuste, Ramón Lecumberri, Juana Schwartz, Félix Alegre, David Filella, Javier Fernández-García, Belén Sádaba, Víctor Jiménez-Yuste, Francisco Carmona-Torre, María Marcos, Pedro Ruiz-Artacho, Cristina Carbonell, Rosa Vidal Laso

Publikováno v: THROMBOSIS AND HAEMOSTASIS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname

Thromboprophylaxis with low molecular weight heparin in hospitalized patients with COVID-19 is mandatory, unless contraindicated. Given the links between inflammation and thrombosis, the use of higher doses of anticoagulants could improve outcomes. W

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9feabfaf8061f9c2ebb329864507ff0
https://pubmed.ncbi.nlm.nih.gov/34638151

Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort

Autor: Natividad Benito, Ignasi Gich, Hèctor Corominas, Rosa M. Antonijoan, Diego Castillo, Isabel Mur, Ana Laiz, Ivan Castellví, Jordi Casademont, Ana Millán, Pere Domingo, David Filella, Virginia Pomar, María Ángeles Quijada, Mireia Puig, Laura Villamarin, Laia Matas

Publikováno v: Clinical Immunology
CLINICAL IMMUNOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Clinical Immunology (Orlando, Fla.)

Although the starting event in COVID-19 is a viral infection some patients present with an over-exuberant inflammatory response, leading to acute lung injury (ALI) and adult respiratory distress syndrome (ARDS). Since IL-6 plays a critical role in th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17dcbb404e41d948b42e93b6de6f7bd0

Correction to: Influence of frailty on anticoagulant prescription and clinical outcomes after 1‑year follow‑up in hospitalised older patients with atrial fibrillation

Autor: Jose I Cuende, Carlos Lahoz, Alejandra Gullón Ojesto, David Filella Agulló, Luis Manzano Espinosa, Miguel Camafort-Babkowski, Jesús Díez-Manglano, JOSE LUIS HERNANDEZ, David Chivite

Publikováno v: Internal and emergency medicine. 14(2)

In the original publication, all the collaborator names were incorrectly tagged and published online. The correct given and family names for the collaborators names should list as follows.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33a9da94af43f43eb7f2fad94bb3170f
https://pubmed.ncbi.nlm.nih.gov/30191535